|
2017 Journal Article A path through the reticulate pigmentation disorder jungleSchaider, H. and Sturm, R. A. (2017). A path through the reticulate pigmentation disorder jungle. British Journal of Dermatology, 177 (4), 893-893. doi: 10.1111/bjd.15805 |
|
2017 Journal Article Tumor-associated B-cells induce tumor heterogeneity and therapy resistanceSomasundaram, Rajasekharan, Zhang, Gao, Fukunaga-Kalabis, Mizuho, Perego, Michela, Krepler, Clemens, Xu, Xiaowei, Wagner, Christine, Hristova, Denitsa, Zhang, Jie, Tian, Tian, Wei, Zhi, Liu, Qin, Garg, Kanika, Griss, Johannes, Hards, Rufus, Maurer, Margarita, Hafner, Christine, Mayerhofer, Marius, Karanikas, Georgios, Jalili, Ahmad, Bauer-Pohl, Verena, Weihsengruber, Felix, Rappersberger, Klemens, Koller, Josef, Lang, Roland, Hudgens, Courtney, Chen, Guo, Tetzlaff, Michael, Wu, Lawrence ... Wagner, Stephan N. (2017). Tumor-associated B-cells induce tumor heterogeneity and therapy resistance. Nature Communications, 8 (1) 607, 607. doi: 10.1038/s41467-017-00452-4 |
|
2017 Journal Article Diphenylcyclopropenone for the treatment of cutaneous in-transit melanoma metastases - results of a prospective, non-randomized, single-centre studyRead, T., Webber, S., Tan, J., Wagels, M., Schaider, H., Soyer, H. P. and Smithers, B. M. (2017). Diphenylcyclopropenone for the treatment of cutaneous in-transit melanoma metastases - results of a prospective, non-randomized, single-centre study. Journal of the European Academy of Dermatology and Venereology, 31 (12), 2030-2037. doi: 10.1111/jdv.14422 |
|
2017 Journal Article Pregnancy as driver for melanomaRichtig, G., Byrom, L., Kupsa, R., Schaider, H., Hofmann-Wellenhof, R., Wolf, I. H., Soyer, H. P. and Richtig, E. (2017). Pregnancy as driver for melanoma. British Journal of Dermatology, 177 (3), 854-857. doi: 10.1111/bjd.15124 |
|
2017 Journal Article Overcoming resistance to targeted therapy with immunotherapy and combination therapy for metastatic melanomaKeller, Hilary R., Zhang, Xin, Li, Li, Schaider, Helmut and Wells, James W. (2017). Overcoming resistance to targeted therapy with immunotherapy and combination therapy for metastatic melanoma. Oncotarget, 8 (43), 75675-75686. doi: 10.18632/oncotarget.18523 |
|
2017 Journal Article In vitro and in vivo cytotoxic activity of human lactoferricin derived antitumor peptide R-DIM-P-LF11-334 on human malignant melanomaRiedl, Sabrina, Rinner, Beate, Schaider, Helmut, Liegl-Atzwanger, Bernadette, Meditz, Katharina, Preishuber-Pfluegl, Julia, Grissenberger, Sarah, Lohner, Karl and Zweytick, Dagmar (2017). In vitro and in vivo cytotoxic activity of human lactoferricin derived antitumor peptide R-DIM-P-LF11-334 on human malignant melanoma. Oncotarget, 8 (42), 71817-71832. doi: 10.18632/oncotarget.17823 |
|
2017 Conference Publication Human lactoferricin derived peptides trigger apoptosis in malignant melanoma in vitro and in vivoRiedl, S., Rinner, B., Schaider, H., Liegl-Atzwanger, B., Wodlej, C., Lohner, K. and Zweytick, D. (2017). Human lactoferricin derived peptides trigger apoptosis in malignant melanoma in vitro and in vivo. 19th IUPAB Congress / 11th EBSA Congress, Edinburgh Scotland, 16-20 July 2017. New York, NY, United States: Springer. |
|
2017 Conference Publication Involution of selective melanocytic lesions in a 79 year-old male with metastatic melanoma on immunotherapyThomas, S., Schaider, H., Laino, A., Adams, L. and Soyer, P. (2017). Involution of selective melanocytic lesions in a 79 year-old male with metastatic melanoma on immunotherapy. Australasian College of Dermatologists 50th Annual Scientific Meeting, Darling Harbour, New South Wales, Australia, 6–9 May 2017. Richmond, VIC., Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/ajd.21_12652 |
|
2016 Journal Article Two case reports of rare BRAF mutations in exon 11 and exon 15 with discussion of potential treatment optionsRichtig, Georg, Aigelsreiter, Ariane, Kashofer, Karl, Talakic, Emina, Kupsa, Romana, Schaider, Helmut and Richtig, Erika (2016). Two case reports of rare BRAF mutations in exon 11 and exon 15 with discussion of potential treatment options. Case Reports in Oncology, 9 (3), 543-546. doi: 10.1159/000449125 |
|
2016 Journal Article Multiparameter analysis of naevi and primary melanomas identifies a subset of naevi with elevated markers of transformationFox, Carly, Lambie, Duncan, Wilmott, James S., Pinder, Alex, Pavey, Sandra, Lê Cao, Kim-Anh, Akalin, Taner, Karaarslan, Isil Kilinc, Ozdemir, Fezal, Scolyer, Richard A., Yamada, Miko, Soyer, H. Peter, Schaider, Helmut and Gabrielli, Brian (2016). Multiparameter analysis of naevi and primary melanomas identifies a subset of naevi with elevated markers of transformation. Pigment Cell and Melanoma Research, 29 (4), 444-452. doi: 10.1111/pcmr.12489 |
|
2016 Journal Article Notch4 signaling induces a mesenchymal- Epithelial-like transition in melanoma cells to suppress malignant behaviorsRad, Ehsan Bonyadi, Hammerlindl, Heinz, Wels, Christian, Popper, Ulrich, Menon, Dinoop Ravindran, Breiteneder, Heimo, Kitzwoegerer, Melitta, Hafner, Christine, Herlyn, Meenhard, Bergler, Helmut and Schaider, Helmut (2016). Notch4 signaling induces a mesenchymal- Epithelial-like transition in melanoma cells to suppress malignant behaviors. Cancer Research, 76 (7), 1690-1697. doi: 10.1158/0008-5472.CAN-15-1722 |
|
2016 Journal Article Heritability of naevus patterns in an adult twin cohort from the Brisbane Twin Registry: A cross-sectional studyLee, S., Duffy, D.L., Mcclenahan, P., Lee, K. J., McEniery, E., Burke, B., Jagirdar, K., Martin, N.G., Sturm, R.A., Soyer, H.P. and Schaider, H. (2016). Heritability of naevus patterns in an adult twin cohort from the Brisbane Twin Registry: A cross-sectional study. British Journal of Dermatology, 174 (2), 356-363. doi: 10.1111/bjd.14291 |
|
2016 Journal Article A distinct expression profile separates Turkish and Australian melanocytic naeviFox, Carly, Schaider, Helmut, Akalin, Taner, Turkmen, Meltem, Sturm, Rick, Lambie, Duncan, Karaarslan, Isil K., Soyer, H. Peter, Ozdemir, Fezal and Gabrielli, Brian (2016). A distinct expression profile separates Turkish and Australian melanocytic naevi. Histopathology, 69 (1), 151-154. doi: 10.1111/his.12906 |
|
2016 Conference Publication Identification of unique molecular signatures of differentially cycling tumour cell subpopulations in a 3D melanoma modelAhmed, F., Tonnessen, C., Spoerri, L., Daignault, S., Stark, M., Schaider, H., Hill, M. and Haass, N. (2016). Identification of unique molecular signatures of differentially cycling tumour cell subpopulations in a 3D melanoma model. Asia-Pacific Combined Dermatology Research Conference 2016, Noosa, QLD Australia, 25–28 August 2016. Richmond, VIC Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/ajd.12584 |
|
2016 Conference Publication Notch4 mediated MET-like transition involves crosstalk with non-canonical WNT signalling in melanomaHammerlindl, H., Rad, E. B., Menon, D. R., Hafner, C., Herlyn, M. and Schaider, H. (2016). Notch4 mediated MET-like transition involves crosstalk with non-canonical WNT signalling in melanoma. Asia‐Pacific Combined Dermatology Research Conference 2016, Noosa, QLD Australia, 25–28 August 2016. Richmond, VIC Australia: Wiley-Blackwell. |
|
2016 Conference Publication Can melanoma treatment be guided by a panel of predictive and prognostic microRNA biomarkers?Stark, M., Gray, E., Ziman, M., Soyer, H. P. and Schaider, H. (2016). Can melanoma treatment be guided by a panel of predictive and prognostic microRNA biomarkers?. 16th World Congress on Cancers of the Skin , Vienna, Austria, 31 August - 3 September 2016. Philadelphia, PA United States: Lippincott Williams & Wilkins. |
|
2016 Conference Publication Global histone modifications define early stress induced drug tolerance in cancerAl Emran, Abdullah, Menon, Dinoop Ravindran, Soyer, Peter, Gabrielli, Brian, Sturm, Rick, Herlyn, Meenhard and Schaider, Helmut (2016). Global histone modifications define early stress induced drug tolerance in cancer. American-Association-for-Cancer-Research (AACR) Special Conference on Chromatin and Epigenetics in Cancer, Atlanta, GA, United States, 24-27 September 2015. Philadelphia, PA United States: American Association for Cancer Research. doi: 10.1158/1538-7445.CHROMEPI15-B34 |
|
2016 Conference Publication Combination of sorafenib with aspirin synergistically target mutant NRAS melanomaMenon, D. R., Hammerlindl, H., Emran, A., Thakkar, D., Soyer, H. P., Herlyn, M., Krepler, C. and Schaider, H. (2016). Combination of sorafenib with aspirin synergistically target mutant NRAS melanoma. Asia‐Pacific Combined Dermatology Research Conference 2016, Noosa, QLD Australia, 25–28 August 2016. Richmond, VIC Australia: Wiley-Blackwell. |
|
2016 Conference Publication Stress induced multi-drug tolerance precedes acquired drug resistance in melanomaSchaider, H., Menon, D. R., Emran, A., Gabrielli, B., Haass, N., Somasundaram, R. and Herlyn, M. (2016). Stress induced multi-drug tolerance precedes acquired drug resistance in melanoma. 26th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics, Barcelona Spain, 18-21 November 2014. Richmond, VIC Australia: Wiley-Blackwell . |
|
2016 Conference Publication Rose Bengal melanoma therapy - phototoxicity versus intrinsic cytotoxicityNierfeld, M., Nascimento, P. R., Baesler, K., Knuever, J., Spoerri, L., Schaider, H., Weninger, W. and Haass, N. K. (2016). Rose Bengal melanoma therapy - phototoxicity versus intrinsic cytotoxicity. Asia-Pacific Combined Dermatology Research Conference 2016, Noosa, QLD Australia, 25–28 August 2016. Richmond, VIC Australia: Wiley-Blackwell Publishing Asia. |
